This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hobisch, A. Articles by Hittmair, A. Search for Related Content PubMed PubMed Citation Articles by Hobisch, A. Articles by Hittmair, A.

Distant Metastases from Prostatic Carcinoma Express Androgen Receptor Protein¹

Departments of Urology [A. Ho., Z. C., C. R., G. B., H. K.] and Pathology [A. Hi.], University of Innsbruck, A-6020 Innsbruck, Austria

Nearly all primary prostatic carcinomas have been found to express the androgen receptor (AR) protein, which is the intracellular mediator of androgen action. To gain a better insight into the mechanisms of androgen independence of advanced prostatic carcinoma, it is important to know whether the AR is also present in metastases of androgen-independent tumors. We have assessed the status of the AR and the prostate-specific antigen in 22 metastases of 18 patients with progressive prostate cancer. In 18 cases, the metastases were localized in bone, in 3 cases in the epidural space, and in 1 case in the periosteum. All but one patient had received some kind of endocrine treatment for prostatic carcinoma. Paraffin-embedded tissue sections were stained for the AR following a streptavidinbiotin-peroxidase protocol with the polyclonal antibody PG-21, which is directed against amino acids 1 through 21 of the rat and the human AR. The percentage of AR-positive cells was evaluated on the basis of an arbitrary 4-point scale. All 22 tumor metastases displayed AR positivity. One AR-positive metastatic lesion did not stain for prostate-specific antigen, but in all other metastases, this protein was detected by means of immunohistochemistry. The present study provides evidence that, unlike androgen-independent prostatic carcinoma cell lines, distant prostatic carcinoma metastases do express the AR. These findings indicate that the AR may be involved in the progression of prostate cancer.

¹ Supported by the Austrian Research Fund (FWF SFB 002 P203).

² To whom requests for reprints should be addressed.

Received 1/25/95. Accepted 5/16/95.

This article has been cited by other articles:

				K. K. Waltering, M. A. Helenius, B. Sahu, V. Manni, M. J. Linja, O. A. Janne, and T. Visakorpi Increased Expression of Androgen Receptor Sensitizes Prostate Cancer Cells to Low Levels of Androgens Cancer Res., October 15, 2009; 69(20): 8141 - 8149. [Abstract] [Full Text] [PDF]

				J. Y. Chun, N. Nadiminty, S. Dutt, W. Lou, J. C. Yang, H.-J. Kung, C. P. Evans, and A. C. Gao Interleukin-6 Regulates Androgen Synthesis in Prostate Cancer Cells Clin. Cancer Res., August 1, 2009; 15(15): 4815 - 4822. [Abstract] [Full Text] [PDF]

				D. Z. Qian, C.-Y. Huang, C. A. O'Brien, I. M. Coleman, M. Garzotto, L. D. True, C. S. Higano, R. Vessella, P. H. Lange, P. S. Nelson, et al. Prostate Cancer-Associated Gene Expression Alterations Determined from Needle Biopsies Clin. Cancer Res., May 1, 2009; 15(9): 3135 - 3142. [Abstract] [Full Text] [PDF]

				N. K. Mukhopadhyay, J. Kim, B. Cinar, A. Ramachandran, M. H. Hager, D. Di Vizio, R. M. Adam, M. A. Rubin, P. Raychaudhuri, A. De Benedetti, et al. Heterogeneous Nuclear Ribonucleoprotein K Is a Novel Regulator of Androgen Receptor Translation Cancer Res., March 15, 2009; 69(6): 2210 - 2218. [Abstract] [Full Text] [PDF]

				R. Snoek, H. Cheng, K. Margiotti, L. A. Wafa, C. A. Wong, E. C. Wong, L. Fazli, C. C. Nelson, M. E. Gleave, and P. S. Rennie In vivo Knockdown of the Androgen Receptor Results in Growth Inhibition and Regression of Well-Established, Castration-Resistant Prostate Tumors Clin. Cancer Res., January 1, 2009; 15(1): 39 - 47. [Abstract] [Full Text] [PDF]

				P. Liu, S. Li, L. Gan, T. P. Kao, and H. Huang A Transcription-Independent Function of FOXO1 in Inhibition of Androgen-Independent Activation of the Androgen Receptor in Prostate Cancer Cells Cancer Res., December 15, 2008; 68(24): 10290 - 10299. [Abstract] [Full Text] [PDF]

				A. Seaton, P. Scullin, P. J. Maxwell, C. Wilson, J. Pettigrew, R. Gallagher, J. M. O'Sullivan, P. G. Johnston, and D. J. J. Waugh Interleukin-8 signaling promotes androgen-independent proliferation of prostate cancer cells via induction of androgen receptor expression and activation Carcinogenesis, June 1, 2008; 29(6): 1148 - 1156. [Abstract] [Full Text] [PDF]

				L. G. Wang, E. M. Johnson, Y. Kinoshita, J. S. Babb, M. T. Buckley, L. F. Liebes, J. Melamed, X.-M. Liu, R. Kurek, L. Ossowski, et al. Androgen Receptor Overexpression in Prostate Cancer Linked to Pur{alpha} Loss from a Novel Repressor Complex Cancer Res., April 15, 2008; 68(8): 2678 - 2688. [Abstract] [Full Text] [PDF]

				J. N. Davis, K. J. Wojno, S. Daignault, M. D. Hofer, R. Kuefer, M. A. Rubin, and M. L. Day Elevated E2F1 Inhibits Transcription of the Androgen Receptor in Metastatic Hormone-Resistant Prostate Cancer Cancer Res., December 15, 2006; 66(24): 11897 - 11906. [Abstract] [Full Text] [PDF]

				D. Gioeli, B. E. Black, V. Gordon, A. Spencer, C. T. Kesler, S. T. Eblen, B. M. Paschal, and M. J. Weber Stress Kinase Signaling Regulates Androgen Receptor Phosphorylation, Transcription, and Localization Mol. Endocrinol., March 1, 2006; 20(3): 503 - 515. [Abstract] [Full Text] [PDF]

				P. A. Watson, K. Ellwood-Yen, J. C. King, J. Wongvipat, M. M. LeBeau, and C. L. Sawyers Context-Dependent Hormone-Refractory Progression Revealed through Characterization of a Novel Murine Prostate Cancer Cell Line Cancer Res., December 15, 2005; 65(24): 11565 - 11571. [Abstract] [Full Text] [PDF]

				J. C. Hsu, J. Zhang, A. Dev, A. Wing, L. F. Bjeldanes, and G. L. Firestone Indole-3-carbinol inhibition of androgen receptor expression and downregulation of androgen responsiveness in human prostate cancer cells Carcinogenesis, November 1, 2005; 26(11): 1896 - 1904. [Abstract] [Full Text] [PDF]

				M. A. Titus, M. J. Schell, F. B. Lih, K. B. Tomer, and J. L. Mohler Testosterone and Dihydrotestosterone Tissue Levels in Recurrent Prostate Cancer Clin. Cancer Res., July 1, 2005; 11(13): 4653 - 4657. [Abstract] [Full Text] [PDF]

				Z Culig, H Steiner, G Bartsch, and A Hobisch Mechanisms of endocrine therapy-responsive and -unresponsive prostate tumours Endocr. Relat. Cancer, June 1, 2005; 12(2): 229 - 244. [Abstract] [Full Text] [PDF]

				M. Sato, M. Johnson, L. Zhang, S. S. Gambhir, M. Carey, and L. Wu Functionality of Androgen Receptor-Based Gene Expression Imaging in Hormone Refractory Prostate Cancer Clin. Cancer Res., May 15, 2005; 11(10): 3743 - 3749. [Abstract] [Full Text] [PDF]

				R. B. Shah, R. Mehra, A. M. Chinnaiyan, R. Shen, D. Ghosh, M. Zhou, G. R. MacVicar, S. Varambally, J. Harwood, T. A. Bismar, et al. Androgen-Independent Prostate Cancer Is a Heterogeneous Group of Diseases: Lessons from a Rapid Autopsy Program Cancer Res., December 15, 2004; 64(24): 9209 - 9216. [Abstract] [Full Text] [PDF]

				H. I Scher, G. Buchanan, W. Gerald, L. M Butler, and W. D Tilley Targeting the androgen receptor: improving outcomes for castration-resistant prostate cancer Endocr. Relat. Cancer, September 1, 2004; 11(3): 459 - 476. [Abstract] [Full Text] [PDF]

				N. Blaszczyk, B. A. Masri, N. R. Mawji, T. Ueda, G. McAlinden, C. P. Duncan, N. Bruchovsky, H.-U. Schweikert, D. Schnabel, E. C. Jones, et al. Osteoblast-Derived Factors Induce Androgen-Independent Proliferation and Expression of Prostate-Specific Antigen in Human Prostate Cancer Cells Clin. Cancer Res., March 1, 2004; 10(5): 1860 - 1869. [Abstract] [Full Text] [PDF]

				F. K. Habib, M. Ross, C. W. Bayne, P. Bollina, K. Grigor, and K. Chapman The Loss of 5{alpha}-Reductase Type I and Type II mRNA Expression in Metastatic Prostate Cancer to Bone and Lymph Node Metastasis Clin. Cancer Res., May 1, 2003; 9(5): 1815 - 1819. [Abstract] [Full Text] [PDF]

				D. J. Lamb, E. Puxeddu, N. Malik, D. L. Stenoien, R. Nigam, G. Y. Saleh, M. Mancini, N. L. Weigel, and M. Marcelli Molecular Analysis of the Androgen Receptor in Ten Prostate Cancer Specimens Obtained Before and After Androgen Ablation J Androl, March 1, 2003; 24(2): 215 - 225. [Abstract] [Full Text] [PDF]

				T. Ueda, N. R. Mawji, N. Bruchovsky, and M. D. Sadar Ligand-independent Activation of the Androgen Receptor by Interleukin-6 and the Role of Steroid Receptor Coactivator-1 in Prostate Cancer Cells J. Biol. Chem., October 4, 2002; 277(41): 38087 - 38094. [Abstract] [Full Text] [PDF]

				D. Masiello, S. Cheng, G. J. Bubley, M. L. Lu, and S. P. Balk Bicalutamide Functions as an Androgen Receptor Antagonist by Assembly of a Transcriptionally Inactive Receptor J. Biol. Chem., July 12, 2002; 277(29): 26321 - 26326. [Abstract] [Full Text] [PDF]

				M. D. Sadar, V. A. Akopian, and E. Beraldi Characterization of a New in Vivo Hollow Fiber Model for the Study of Progression of Prostate Cancer to Androgen Independence Mol. Cancer Ther., June 1, 2002; 1(8): 629 - 637. [Abstract] [Full Text] [PDF]

				K. Fizazi, L. A. Martinez, C. R. Sikes, D. A. Johnston, L. C. Stephens, T. J. McDonnell, C. J. Logothetis, J. Trapman, L. L. Pisters, N. G. Ordonez, et al. The Association of p21(WAF-1/CIP1) with Progression to Androgen-independent Prostate Cancer Clin. Cancer Res., March 1, 2002; 8(3): 775 - 781. [Abstract] [Full Text] [PDF]

				M. E. Grossmann, H. Huang, and D. J. Tindall Androgen Receptor Signaling in Androgen-Refractory Prostate Cancer J Natl Cancer Inst, November 21, 2001; 93(22): 1687 - 1697. [Abstract] [Full Text] [PDF]

				Long. G. Wang, L. Ossowski, and A. C. Ferrari Overexpressed Androgen Receptor Linked to p21WAF1 Silencing May Be Responsible for Androgen Independence and Resistance to Apoptosis of a Prostate Cancer Cell Line Cancer Res., October 1, 2001; 61(20): 7544 - 7551. [Abstract] [Full Text] [PDF]

				F. Andriani, B. Nan, J. Yu, X. Li, N. L. Weigel, M. J. McPhaul, S. Kasper, S. Kagawa, B. Fang, R. J. Matusik, et al. Use of the Probasin Promoter ARR2PB to Express Bax in Androgen Receptor-Positive Prostate Cancer Cells J Natl Cancer Inst, September 5, 2001; 93(17): 1314 - 1324. [Abstract] [Full Text] [PDF]

				D.-L. Lin, M. C. Whitney, Z. Yao, and E. T. Keller Interleukin-6 Induces Androgen Responsiveness in Prostate Cancer Cells through Up-Regulation of Androgen Receptor Expression Clin. Cancer Res., June 1, 2001; 7(6): 1773 - 1781. [Abstract] [Full Text] [PDF]

				M. J. Linja, K. J. Savinainen, O. R. Saramäki, T. L. J. Tammela, R. L. Vessella, and T. Visakorpi Amplification and Overexpression of Androgen Receptor Gene in Hormone-Refractory Prostate Cancer Cancer Res., May 1, 2001; 61(9): 3550 - 3555. [Abstract] [Full Text]

				G. Buchanan, N. M. Greenberg, H. I. Scher, J. M. Harris, V. R. Marshall, and W. D. Tilley Collocation of Androgen Receptor Gene Mutations in Prostate Cancer Clin. Cancer Res., May 1, 2001; 7(5): 1273 - 1281. [Abstract] [Full Text]

				C. Abate-Shen and M. M. Shen Molecular genetics of prostate cancer Genes & Dev., October 1, 2000; 14(19): 2410 - 2434. [Full Text]

				K.-i. Nakashiro, M. Okamoto, Y. Hayashi, and R. Oyasu Hepatocyte Growth Factor Secreted by Prostate-Derived Stromal Cells Stimulates Growth of Androgen-Independent Human Prostatic Carcinoma Cells Am. J. Pathol., September 1, 2000; 157(3): 795 - 803. [Abstract] [Full Text] [PDF]

				H. Kinoshita, Y. Shi, C. Sandefur, L. F. Meisner, C. Chang, A. Choon, C. R. Reznikoff, G. S. Bova, A. Friedl, and D. F. Jarrard Methylation of the Androgen Receptor Minimal Promoter Silences Transcription in Human Prostate Cancer Cancer Res., July 1, 2000; 60(13): 3623 - 3630. [Abstract] [Full Text]

				S. McDonald, L. Brive, D. B. Agus, H. I. Scher, and K. R. Ely Ligand Responsiveness in Human Prostate Cancer: Structural Analysis of Mutant Androgen Receptors from LNCaP and CWR22 Tumors Cancer Res., May 1, 2000; 60(9): 2317 - 2322. [Abstract] [Full Text]

				N. M. Navone, M. d. C. Rodriguez-Vargas, W. F. Benedict, P. Troncoso, T. J. McDonnell, J.-H. Zhou, R. Luthra, and C. J. Logothetis TabBO: A Model Reflecting Common Molecular Features of Androgen-independent Prostate Cancer Clin. Cancer Res., March 1, 2000; 6(3): 1190 - 1197. [Abstract] [Full Text]

				M. Marcelli, M. Ittmann, S. Mariani, R. Sutherland, R. Nigam, L. Murthy, Y. Zhao, D. DiConcini, E. Puxeddu, A. Esen, et al. Androgen Receptor Mutations in Prostate Cancer Cancer Res., February 1, 2000; 60(4): 944 - 949. [Abstract] [Full Text]

				A. P. Stubbs, P. D. Abel, M. Golding, G. Bhangal, Q. Wang, J. Waxman, G. W.H. Stamp, and E.-N. Lalani Differentially Expressed Genes in Hormone Refractory Prostate Cancer : Association with Chromosomal Regions Involved with Genetic Aberrations Am. J. Pathol., May 1, 1999; 154(5): 1335 - 1343. [Abstract] [Full Text] [PDF]

				E. Ruijter, C. van de Kaa, G. Miller, D. Ruiter, F. Debruyne, and J. Schalken Molecular Genetics and Epidemiology of Prostate Carcinoma Endocr. Rev., February 1, 1999; 20(1): 22 - 45. [Abstract] [Full Text]

				J. M. Kokontis, N. Hay, and S. Liao Progression of LNCaP Prostate Tumor Cells during Androgen Deprivation: Hormone-Independent Growth, Repression of Proliferation by Androgen, and Role for p27Kip1 in Androgen-Induced Cell Cycle Arrest Mol. Endocrinol., July 1, 1998; 12(7): 941 - 953. [Abstract] [Full Text]

				G. J. Bubley and S. P. Balk Treatment of Androgen-Independent Prostate Cancer Oncologist, February 1, 1996; 1(1): 30 - 35. [Abstract] [Full Text] [PDF]

				G. Han, B. A. Foster, S. Mistry, G. Buchanan, J. M. Harris, W. D. Tilley, and N. M. Greenberg Hormone Status Selects for Spontaneous Somatic Androgen Receptor Variants That Demonstrate Specific Ligand and Cofactor Dependent Activities in Autochthonous Prostate Cancer J. Biol. Chem., March 30, 2001; 276(14): 11204 - 11213. [Abstract] [Full Text] [PDF]